View Report Details
Global In Vitro Diagnostics (IVD) Market ----------------------------------------------------------2012
View Report Details Executive Summary In-vitro diagnostic (IVD) tests are intended to perform examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information concerning physiological or pathological state, or concerning congenital abnormality. In-vitro diagnostics accounts for a major share in the global diagnostics market. The global IVD market has been experiencing rapid growth, inspite of the economic recession. On the basis of technology, clinical biochemistry dominates the global IVD market, followed by immunoassays and molecular biology. Some other segments are expected to register rapid growth in the coming years. On the basis of customer segments, clinical lab is the largest segment followed by point-of-care and research labs. Point-of-care customer segment offers diagnostic services at or near the site of the patient. Glucose monitoring recorded the largest share in the point-of-care segment. Globally, North America, Europe and Japan are the largest IVD markets. In Europe, the largest markets are Germany, France and Italy. India, China and Brazil are the emerging IVD markets which will register high growth in the coming years. The main drivers of IVD industry discussed in this report are increasing ageing population, growing diabetic population, high insurance density and low vitamin D penetration. Also, there are some key trends which include significant merger and acquisition activity in the industry. IVD market faces various challenges in the face of stringent regulations. Global IVD industry is consolidated with the top six players competing for a major share in the market which includes Roche, the market leader, followed by Abbott, Seimens, Johnson and Johnson, Danaher and biomerieux. The report analyzes the IVD market on a global scale and its various segments and also provides detailed information regarding the key regional market, Europe as well as the emerging economies, India, China and Brazil. It further discusses the various trends and challenges of the global IVD market. It profiles the three major pharmaceutical players involved in IVD testing - Roche Holdings, Siemens AG and Abbott Laboratories. By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
IVD refers to testing that aims for the identification of disease states outside the body, using such samples as body fluids (blood, urine) and tissues (biopsies and tissue sections). Global Diagnostics Market (2005-2012E)
•The global diagnostics market was valued at US$.... billion in 2005, which increased up to US$..... billion in the year end 2011 at the compound annual growth rate of ….% during the cited period. The market is expected to grow by ….% to US$..... billion in 2012 in comparison with 2011. US$ Billion
•As of 2011, the global IVD market showed an increase of approximately ……% rising from US$....... billion in 2010 to US$........ billion in 2011. The same registered a CAGR of approximately ……% for period spanning 2006 to 2011. •IVD market is divided in three main customer segments based on the purpose of IVD tests viz. clinical labs, point-of care and research labs. Clinical labs reported the highest share of …% in 2011 in comparison with other segments.
2005
2006
2007
2008
2009
2010
2011 2012E •Industry Developments and trends: -Growing Market for Point of Care Diagnostics -Emerging Korean Molecular Diagnostics Business -Mergers and Acquisitions
Global IVD Market (2006-2011)
US$ Billion
Market Growth Drivers - Ageing Population - Diabetic Population -Increasing Insurance Density -Low Penetration of Vitamin D Tests
2006
2007
2008
2009
2010
2011
IVD market is classified in terms of application, technology, disease area, product category and end sites. Global IVD Market by Technology (2011) The segment of clinical biochemistry accounted for …..% of the global IVD market, followed by Immunoassays accounting for ……% of the market. Also, Molecular biology and Hematology and flow cytometry accounted for …..% each share in the total value of the global in-vitro diagnostics market.
)
As of 2011, the North American market share, largest in the market, was ……% of the global IVD market. Europe held ……% share, followed by Japan with ……% against the same period.
Clinical biochemistry Molecular biology Microbiology Hemostasis
Immunoassays Hematology and flow cytometry Histology and cytology Other technologies
Europe is considered to be one of the mature markets for in-vitro diagnostics worldwide. The market was valued at US$.... million in 2011, witnessing a growth of around …….% as compared to US$........million in 2010.
IVD Market in the European Union (2007-2011) Global IVD Market by Region (2011)
North America
Europe
Japan
Others
EU-27
EU-27+EFTA
2011
2010
2009
2008
2007
US$ Billion
)
The Global IVD Market is highly fragmented and companies face intense competition. In 2011, the market leader in terms of revenue was Roche.
US$ Billion
Global In Vitro Diagnostics Market (2010-2015F)
2010
2011
2012F
2013F
2014F
Revenues of the Chinese IVD market showed a growth of approximately …..% increasing from US$.... billion in 2009 to US$..... billion in 2011. In 2011, the Indian IVD market reported revenues of US$..... million showing a growth of approximately …….% in comparison with US$...... million in 2008. Also in 2012, the IVD market of Brazil reported an increase of …….% by reaching US$...... . On the competition front, Roche is the leading company in the market for IVD world over, with approximately ……% of the market share for the year 2011, followed by Abbott with ……% and Seimens with …..%. The global market for IVD is valued at US$...... billion in 2011 and is expected to grow at a CAGR of …..% and reach US$.…. billion by the end of 2014. One of the key Issues faced by the respective industry include stringent regulations imposed on the companies operating in the very field.
Note: Market attractiveness is inverse of penetration. Low penetration means high attractiveness and vice-versa
Table of Contents
List of Graphs & Tables
1. IVD: An Overview List of Charts
1.1 Uses of IVDs 1.2 Market Segments 1.3 IVD Value Chain 2. Global Market Analysis 2.1 Diagnostic Market 2.2 Global IVD Market 2.2.1 Overview -Market Value -Major Companies by Segments 2.2.2 IVD Market Segments -By Technology -By Customer Segment -By Region 3. Principal IVD Markets 3.1 European Union -Overall Market Value -Market Value by Countries
3.2 China -Market Overview -Market Value 3.3 India -Market Overview -Market Value
3.4 Brazil -Market Overview -Market Value
IVD Market – Segments by Technology IVD Market – End Users IVD Value Chain Analysis in Medical Application Global Diagnostics Market (2005-2012E) Global IVD Market (2006-2011) Global IVD Market by Technology (2011) Global IVD Market by Customer Segment (2011) Global Point-of-care Market by Major Segments (2009-2011) Global IVD Market by Region (2011) IVD Market in the European Union (2007-2011) European IVD Market Revenues (2006-2011) IVD Market in the Europe – by Countries (2011) China IVD Market Revenues (2000-2011) India IVD Market Revenues (2001-2011) Brazil IVD Market Revenues (2003-2012) Ageing Population Worldwide, age>65 (2005-2015) World Population with Diabetes, Age Group 20-79 years (2006-2012) Global Insurance Density (2004-2011) Global vitamin D Market (2007-2011) Vitamin D Tests Penetration by Region (2011E) The US Vitamin D Tests Market (2011E-2015E) Europe Vitamin D Tests Market (2011E-2015E) Brazil Vitamin D Tests Market (2011E-2015E) No. of IVD M&A’s per year (2009-2012) No. of M&A Deals According to Primary IVD Target Company (20092012) No. of IVD Partnership Deals by Type (2009-2012) Global IVD Market – Share Breakdown by Company (2011) IVD Players in Brazil (2011) Immunoassays Market Share (2012E) Number of Tests Available on Main Immunoassays Platform (2011)
4. Market Dynamics 4.1 Growth Drivers 4.1.1 Ageing Population 4.1.2 Diabetic Population 4.1.3 Increasing Insurance Density 4.1.4 Low Penetration of Vitamin D Tests 4.2 Key Trends 4.2.1 Growing Market for Point of Care Diagnostics 4.2.2 Emerging Korean Molecular Diagnostics Business 4.2.3 Mergers and Acquisitions 4.3 Challenges 4.3.1 Stringent Regulations 5. IVD Market - Competitive Landscape 5.1 Worldwide Competition 5.1.1 Competition in Brazil 5.2 Competition by Segments -Immunoassay -Molecular Biology -Microbiology
5.3 Competition by Company Performance -Revenues -Operating Margin -R&D Expenditure 6. Company Profiles 6.1 Roche Holdings AG
Molecular Biology Market Share (2012E) Microbiology Market Share (2012E) Sales of IVD Players (2011) Operating Margins of the IVD Players (2011) R&D Spending of Major Pure IVD Players (2011) Roche Revenue – Share by Segments (2011) Roche Holdings Revenue and Net Income (2007-2011) Siemens AG’s Revenue Share by Business Segments (2011) Siemens AG’s Revenues and Net Income (2008-2012) Abbott Laboratories Revenue – Share by Segments (2011) Abbott Laboratories Revenue (2007-2011) Global In Vitro Diagnostics Market (2010-2015E)
List of Tables IVD Market Key Players-by Segments Global IVD Market by Technology (2005-2011) Country-wise Division of European IVD Market (2011) Main M&A Deals in the IVD Sector (2009-2012) Dependent & Independent Variables (2005–2010) Correlation Matrix Model Summary – Coefficient of Determination Regression Coefficients Output
6.1.1 Business Overview 6.1.2 Financial Overview 6.1.3 Business Strategies -Personalized Healthcare -Focus on Innovation 6.2 Siemens AG 6.2.1 Business Overview 6.2.2 Financial Overview 6.2.3 Business Strategies -Accelerating R&D Activities -Focus on Healthcare Segment 6.3 Abbott Laboratories
6.3.1 Business Overview 6.3.2 Financial Highlights 6.3.3 Business Strategies -Mergers and Acquisitions -Expansion in Emerging Markets 7. Market Outlook 7.1 Market Forecast 7.2 Forecast Methodology 7.2.1 Dependent and Independent Variables 7.2.2 Correlation Analysis 7.2.3 Regression Analysis
View Report Contact Us:Details These are abridged and sanitized sample pages from the comprehensive report on the “Global In Vitro Diagnostics (IVD) Market”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com